Neuroethics: The ethical, legal, and societal impact of neuroscience

Annual Review of Psychology

Volumn 63, Issue , 2012, Pages 571-591

  Farah, Martha J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain imaging; Enhancement; Free will; Privacy; Soul

Indexed keywords

BRAIN; BRAIN MAPPING; ETHICS; HUMAN; LEGAL ASPECT; MORALITY; NEUROSCIENCE; PERSONAL AUTONOMY; REVIEW;

BRAIN; BRAIN MAPPING; HUMANS; MORALS; NEUROSCIENCES; PERSONAL AUTONOMY;

EID: 82955184435     PISSN: 00664308     EISSN: 15452085     Source Type: Book Series    
DOI: 10.1146/annurev.psych.093008.100438     Document Type: Review

References (99)

1. Aggarwal NK. 2009. Neuroimaging, culture, and forensic psychiatry. J. Am. Acad. Psychiatry Law 37(2):239-44
2. Aguirre GK. 2010. Experimental design and data analysis for fMRI. In BOLD fMRI: A Guide to Functional Imaging for Neuroscientists, ed. SH Faro, FB Mohamed, pp. 55-69. New York: Springer
3. Aron A, Badre D, Brett M, Cacioppo J, Chambers C, et al. 2007. Politics and the brain. N.Y. Times, Nov. 14
4. Arrington M. 2008. How many Silicon Valley startup executives are hopped up on Provigil? TechCrunch, July 15. http://techcrunch.com/2008/07/15/how-many- of-our-startup-executives-are-hopped-up-on-provigil/
5. Banjo OC, Nadler R, Reiner PB. 2010. Physician attitudes towards pharmacological cognitive enhancement: Safety concerns are paramount. PLoS One 5(12):e14322
6. Baumgartner T, Heinrichs M, Vonlanthen A, Fischbacher U, Fehr E. 2008. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron 58(4):639-50 (Pubitemid 351672358)
7. Bennett CM, Wolford GL, Miller MB. 2009. The principled control of false positives in neuroimaging. Soc. Cogn. Affect. Neurosci. 4:417-22
8. Berman ME, McCloskey MS, Fanning JR, Schumacher JA, Coccaro EF. 2009. Serotonin augmentation reduces response to attack in aggressive individuals. Psychol. Sci. 20:714-20
9. Bles M, Haynes JD. 2008. Detecting concealed information using brain-imaging technology. Neurocase 14:82-92 (Pubitemid 351974048)
10. Borin E. 2003. The U.S. military needs its speed. Wired, Feb. 10. http://www.wired.com/medtech/health/news/2003/02/57434
11. Bourget D, Bradford JMW. 2008. Evidential Basis for the Assessment and Treatment of Sex Offenders. London: Oxford Univ. Press
12. Burkitt L. 2009. Neuromarketing: Companies use neuroscience for consumer insights. Forbes, Nov. 16
13. Chatterjee A. 2009. A medical view of potential adverse effects. Nature 457:532-33
14. Christ SE, Van Essen DC, Watson JM, Brubaker LE, McDermott KB. 2009. The contributions of prefrontal cortex and executive control to deception: evidence from activation likelihood estimate meta-analyses. Cereb. Cortex 19(7):1557-66
15. Coccaro EF, McCloskey MS, Fitzgerald DA, Phan KL. 2007. Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression. Biol. Psychiatry 62(2):168-78 (Pubitemid 46963248)
16. Comm. Sci. Law, Assoc. Bar City N.Y. 2005. Are your thoughts your own? Neuroprivacy and the legal implications of brain imaging. ABCNY Rep., June. http://www.abcny.org/pdf/report/Neuroprivacy-revisions.pdf
17. Crick F. 1995. The Astonishing Hypothesis: The Scientific Search for the Soul. New York: Touchstone Dando M. 2009. Biologists napping while work militarized. Nature 460:950-51
18. Delgado MR. 2007. Reward-related responses in the human striatum. Ann. N.Y. Acad. Sci. 1104:70-88 (Pubitemid 47092728)
19. DeSantis AD, Noar SM, Webb EM. 2009. Nonmedical ADHD stimulant use in fraternities. J. Stud. Alcohol. Drugs 70:952-54
20. Diller LH. 1996. The run on Ritalin: attention deficit disorder and stimulants in the 1990s. Hastings Center Rep. 25:12-18
21. Donaldson ZR, Young LJ. 2008. Oxytocin, vasopressin, and the neurogenetics of sociality. Science 322:900-4
22. Dumit J. 2004. Picturing Personhood: Brain Scans and Biomedical Identity. Princeton, NJ: Princeton Univ. Press
23. Elliott R, Ogilvie A, Rubinsztein JS, Calderon G, Dolan RJ, Sahakian BJ. 2004. Abnormal ventral frontal response during performance of an affective go/no go task in patients with mania. Biol. Psychiatry 55(12):1163-70 (Pubitemid 38739450)
24. Farah M. 2007. This is your brain on politics? Neuroethics & Law Blog, Nov. 12. http://kolber.typepad.com/ethics-law-blog/2007/11/this-is-your- br.html
25. Farah MJ, Heberlein AS. 2007. Personhood and neuroscience: naturalizing or nihilating? Am. J. Bioeth. Neurosci. 7:37-48
26. Farah MJ, Smith ME, Gawuga C, Lindsell D, Foster D. 2009. Brain imaging and brain privacy: a realistic concern? J. Cogn. Neurosci. 21(1):119-27
27. Fitzhenry D, Sandberg L. 2005. Female sexual dysfunction. Nat. Rev. Drug Discov. 4:99-100
28. Fukuyama F. 2002. Our Posthuman Future. London: Profile Books
29. Greenwald AG, McGhee DE, Schwartz JL. 1998. Measuring individual differences in implicit cognition: the implicit association test. J. Personal. Soc. Psychol. 1464-80 (Pubitemid 128658112)
30. Gurley JR, Marcus DK. 2008. The effects of neuroimaging and brain injury on insanity defenses. Behav. Sci. Law 26:85-97 (Pubitemid 351548342)
31. Hackshaw A. 2009. A Concise Guide to Clinical Trials. Oxford, UK: BMJ Books
32. Hamann S, Canli T. 2004. Individual differences in emotion processing. Curr. Opin. Neurobiol. 14(2):233-38 (Pubitemid 38479942)
33. Hamilton R, Messing S, Chatterjee A. 2011. Rethinking the thinking cap: ethics of neural enhancement using noninvasive brain stimulation. Neurology 76:187-93
34. Hart-Davis A. 2005. The Genius Pill: Would you be an idiot to take it? The Evening Standard, Nov. 22
35. Healy D. 2004. Let Them Eat Prozac. New York: NYU Press
36. Hubert M, Kenning P. 2008. A current overview of consumer neuroscience. J. Consum. Behav. 7(4-5):272-92
37. Hughes V. 2010. Science in court: head case. Nature 464(7287):340-42
38. Hyman SE. 2004. Introduction: the brain's special status. Cerebrum 6(4):9-12
39. Iacoboni M. 2007. This is your brain on politics. N.Y. Times, Nov. 11
40. Iacoboni M. 2008. Iacoboni responds to neuropolitics criticism. Neuroethics & Law Blog, June 3. http://kolber.typepad.com/ethics-law-blog/ 2008/06/iacoboni-respon.html
41. Illes J, Kirschen MP, Edwards E, Stanford LR, Bandettini P, et al. 2004. Incidental findings in brain imaging research. Science 311:783-84
42. Kant I. 1996. Critique of Pure Reason. Indianapolis, IN: Hackett
43. Karlawish J. 2011. Addressing the ethical, policy, and social challenges of diagnosing pre-clinical Alzheimer's disease. Neurology 77:1487-93
44. Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, et al. 1998. Selective alteration of personality and social behavior by serotonergic intervention. Am. J. Psychiatry 155:373-79 (Pubitemid 28114895)
45. Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. 2005. Oxytocin increases trust in humans. Nature 435(7042):673-76 (Pubitemid 40825511)
46. Kramer PD. 1997. Listening to Prozac: A Psychiatrist Explores Antidepressant Drugs and the Remaking of the Self-Revised Edition. New York: Penguin
47. Langleben DD, Schroeder L, Maldjian JA, Gur RC, McDonald S, et al. 2002. Brain activity during simulated deception: an event-related functional magnetic resonance study. NeuroImage 15:727-32 (Pubitemid 34852541)
48. Langleben DD, Loughead JW, Ruparel K, Hakun JG, Busch-Winokur S, et al. 2009. Reduced prefrontal and temporal processing and recall of high "sensation value" ads. NeuroImage 46(1):219-25
49. Larriviere D, Williams MA, Rizzo M, Bonnie RJ, AAN Ethics, Law & Humanit. Comm. 2009. Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee. Neurology 73(17):1406-12
50. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, et al. 2001. Diffusion tensor imaging: concepts and applications. J. Magn. Reson. Imaging 13:534-46 (Pubitemid 32231507)
51. Lee N, Broderick AJ, Chamberlain L. 2007. What is " neuromarketing"? A discussion and agenda for future research. Int. J. Psychophysiol. 63:199-204 (Pubitemid 46096609)
52. Leshner AI. 1997. Addiction is a brain disease, and it matters. Science 278:45-47 (Pubitemid 27446268)
53. Lieberman MD. 2007. Social cognitive neuroscience: a review of core processes. Annu. Rev. Psychol. 58:259-89
54. Lindstrom M. 2008. Buyology: Truth and Lies About Why We Buy. New York: Random
55. Lo B, Field MJ. 2009. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: Natl. Acad. Press
56. Madrigal A. 2008. Wired.com readers' brain-enhancing drug regimens. Wired, April 24. http://www. wired.com/medtech/drugs/news/2008/04/smart-drugs
57. Maher B. 2008. Poll results: look who's doping. Nature 452:674-75 (Pubitemid 351521058)
58. Marshall E. 2004. A star-studded search for memory-enhancing drugs. Science 304:36-38 (Pubitemid 38451441)
59. McCabe DP, Castel AD. 2007. Seeing is believing: the effect of brain images on judgments of scientific reasoning. Cognition 107(1):343-52 (Pubitemid 351375186)
60. McCabe SE, Knight JR, Teter CJ, Wechsler H. 2005. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 100:96-106
61. Mechelli A, Price CJ, Friston KJ, Ashburner J. 2005. Voxel-based morphometry of the human brain: methods and applications. Curr. Med. Imaging Rev. 1:105-13
62. Monterosso J, Royzman EB, Schwartz B. 2005. Explaining away responsibility: effects of scientific explanation on perceived culpability. Ethics Behav. 15:139-58 (Pubitemid 41624823)
63. Moreno JD. 2006. Mind Wars: Brain Research and National Defense. New York: Dana Press
64. Morse SJ. 2005. Brain overclaim syndrome and criminal responsibility: a diagnostic note. Ohio State J. Criminal Law 3:397-412
65. Olfson M, Marcus SC. 2009. National patterns in antidepressant medication treatment. Arch. Gen. Psychiatry 66:848-56
66. Parens E. 2004. Genetic differences and human identities:onwhy talking about behavioral geneticsisimportant and difficult. Hastings Center Rep. 34:S1-36
67. Phan KL, Wager T, Taylor SF, Liberzon I. 2002. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. NeuroImage 16(2):331-48 (Pubitemid 34852450)
68. Phelps EA, O'Conner KJ, Cunningham WA, Funayama ES, Gatenby JC, et al. 2000. Performance on indirect measures of race evaluation predicts amygdala activation. J. Cogn. Neurosci. 12(5):729-38
69. Plotz D. 2003. Wake up, Little Susie: Can we sleep less? Slate, March 7
70. Poldrack R. 2008. Poldrack replies to Iacoboni neuropolitics discussion. Neuroethics & Law Blog, June 3. http://kolber.typepad.com/ethics-law-blog/ 2008/06/poldrack-replie.html
71. Posner MI, Raichle ME. 1994. Images of Mind. New York: Sci. Am. Books
72. Racine E, Bar-Ilan O, Illes J. 2005. fMRI in the public eye. Nat. Rev. Neurosci. 6(2):159-64 (Pubitemid 40188949)
73. Ramsey JD, Hanson SJ, Hanson C, Halchenko YO, Poldrack RA, Glymour C. 2010. Six problems for causal inference from fMRI. NeuroImage 49:1545-58
74. Rasmussen N. 2008. On Speed: The Many Lives of Amphetamine. New York: NYU Press
75. Rilling J, Gutman D, Zeh T, Pagnoni G, Berns G, Kilts C. 2002. A neural basis for social cooperation. Neuron 35(2):395-405 (Pubitemid 34876740)
76. Ring RH, Schechter LE, Leonard SK, Dwyer JM, Platt BJ, et al. 2010. Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist. Neuropharmacology 58:69-77
77. Rogers RD, Robbins TW. 2001. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr. Opin. Neurobiol. 11:250-57 (Pubitemid 32289414)
78. Roskies AL. 2008. Neuroimaging and inferential distance. Neuroethics 1(1):19-30
79. Sahakian B, Morein-Zamir S. 2007. Professor's little helper. Nature 450:1157-59
80. Savulescu J, Sandberg A. 2008. Neuroenhancement oflove and marriage: the chemicals between us. Neuroethics 1:31-44
81. Schauer F. 2010. Neuroscience, lie-detection, and the law: a contrarian view. Trends Cogn. Sci. 14:101-3
82. Sessa B. 2007. Is there a case for MDMA-assisted psychotherapy in the UK? J. Psychopharmacol. 21(2):220-24 (Pubitemid 46280475)
83. Silver LM. 1997. Remaking Eden: Cloning and Beyond in a Brave New World. New York: Avon Books
84. Singer E. 2009. Manipulating memory. Technol. Rev. 54. http://www.technologyreview.com/biomedicine/22451/
85. Smith ME, Farah MJ. 2011. Are prescription stimulants "smart pills?" The epidemiology and cognitive neu-roscience of prescription stimulant use by normal healthy individuals. Psychol. Bull. 137:717-41
86. Talbot M. 2009. Brain gain. The underground world of " neuroenhancing" drugs. New Yorker, April 27. http://www.newyorker.com/ reporting/2009/04/27/090427fa-fact-talbot
87. Tang TZ. 2009. Personality change during depression treatment: a placebo-controlled trial. Arch. Gen. Psychiatry 66(12):1322-30
88. Tovino SA. 2007. Imaging body structure and mapping brain function: a historical approach. Am. J. Law Med. 33:19
89. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ. 2003. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl.) 165:260-69 (Pubitemid 36197601)
90. Van Gestel S, Van Broeckhoven CV. 2003. Genetics of personality: Are we making progress? Mol. Psychiatry 8:840-52 (Pubitemid 37346539)
91. Verdejo-Garcia A, Lopez-Torrecillas F, Gimenez CO, Perez-Garcia M. 2004. Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. Neuropsychol. Rev. 14:1-41 (Pubitemid 39023955)
92. Vohs KD, Schooler JW. 2008. The valueofbelieving in free will: Encouragingabeliefindeterminism increases cheating. Psychol. Sci. 19:49-54
93. Volkow ND, Swanson JM. 2008. The action of enhancers can lead to addiction. Nature 451:521
94. Vul E, Harris C, Winkielman P, Pashler H. 2009. Puzzlingly high correlations in fMRI studies of emotion, personality, and social cognition. Perspect. Psychol. Sci. 4:274-90
95. Walsh MT, Dinan TG. 2001. Selective serotonin reuptake inhibitors and violence: a review of the available evidence. Acta Psychiatr. Scand. 104(2):84-91 (Pubitemid 32656082)
96. Weinberg S. 1993. The First Three Minutes: A Modern View of the Origin of the Universe-Updated. New York: Basic Books
97. Westen D, Blagov PS, Harenski K, Kilts C, Hamann S. 2006. Neural bases of motivated reasoning: an FMRI study of emotional constraints on partisan political judgment in the 2004 U.S. Presidential election. J. Cogn. Neurosci. 18:1947-58 (Pubitemid 44674292)
98. Woodward AL. 2009. Infants' grasp of others' intentions. Curr. Dir. Psychol. Sci. 18:53-57
99. Zak PJ, Stanton AA, Ahmadi S. 2007. Oxytocin increases generosity in humans. PLoS One 2:e1128